Cargando…
The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients
INTRODUCTION: The pathophysiology of the Corona Virus Disease 2019 (COVID-19) is incompletely known. A robust inflammatory response caused by viral replication is a main cause of the acute lung and multiorgan injury observed in critical patients. Inflammasomes are likely players in COVID-19 pathogen...
Autores principales: | Vultaggio-Poma, Valentina, Sanz, Juana Maria, Amico, Andrea, Violi, Alessandra, Ghisellini, Sara, Pizzicotti, Stefano, Passaro, Angelina, Papi, Alberto, Libanore, Marco, Di Virgilio, Francesco, Giuliani, Anna Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196164/ https://www.ncbi.nlm.nih.gov/pubmed/37215142 http://dx.doi.org/10.3389/fimmu.2023.1182454 |
Ejemplares similares
-
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels
por: Giuliani, Anna Lisa, et al.
Publicado: (2019) -
The Coming of Age of the P2X7 Receptor in Diagnostic Medicine
por: Di Virgilio, Francesco, et al.
Publicado: (2023) -
Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine
por: Chiozzi, Paola, et al.
Publicado: (2019) -
Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation
por: Di Virgilio, Francesco, et al.
Publicado: (2018) -
P2X7: a receptor with a split personality that raises new hopes for anti-cancer therapy
por: Sarti, Alba Clara, et al.
Publicado: (2021)